Announce Date | 04/29/2025 |
EPS Normalized Actual | $-0.54 (Miss by $-0.35) |
EPS GAAP Actual | $-0.54 (Miss by $-0.35) |
Revenue Actual | $2.794B |
Revenue Surprise | Beat by $2794M |
Announce Date | 06/30/2025 (Pre-Market) |
EPS Normalized Estimate | $0.64322 |
EPS GAAP Estimate | $0.64322 |
Revenue Estimate | $3.0332015B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Dec 2027 | 0 | INF | 0 | 0 | 2 |
Dec 2026 | 3.51362 | 7.98 | 2.65 | 4.67 | 4 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ1 2025 (Mar 2025) | -0.54 | -0.88902 | 2.794B | 1.86% | -135.9M |
FQ4 2024 (Dec 2024) | 0.0512 | 0.0512 | 2.799B | -0.93% | 2799M |
FQ3 2024 (Sep 2024) | 0.44 | 0.44 | 2.874B | -4.18% | 2874M |
FQ2 2024 (Jun 2024) | -0.56 | -0.56 | 2.83B | -1.73% | 2830M |
FQ1 2024 (Mar 2024) | -0.73 | -0.73 | 2.742B | -3.21% | 2742M |
FQ4 2023 (Dec 2023) | 0 | 0 | 2.825B | 0.14% | 2825M |
FQ3 2023 (Sep 2023) | 0.87 | 0.87 | 2.994B | 3.57% | 2994M |
FQ2 2023 (Jun 2023) | 4.28 | 4.28 | 2.879B | 2.01% | 2879M |
FQ4 Announce Date
06/30/2025 (Pre-Market)
Consensus EPS Estimates
0.64322
Consensus Revenue Estimates
3.0332015B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ3 2027 (Sep 2027) | 0.62851 | -- | 0.60604 | 0.65222 | 1 |
FQ2 2027 (Jun 2027) | 0.55481 | -- | 0.53497 | 0.57574 | 1 |
FQ1 2027 (Mar 2027) | 0.19188 | -- | 0.18502 | 0.19912 | 1 |
FQ4 2026 (Oct 2026) | 0.83093 | -- | 0.79329 | 0.86546 | 3 |
FQ3 2026 (Jul 2026) | 0.54838 | -- | 0.52354 | 0.57117 | 5 |
FQ2 2026 (Jun 2026) | 0.75901 | -- | 0.73524 | 0.79045 | 3 |
FQ1 2026 (Mar 2026) | 0.54834 | 198.48 | 0.53117 | 0.57105 | 6 |
FQ4 2025 (Oct 2025) | 0.8082 | 93.66 | 0.77159 | 0.84178 | 4 |
FQ3 2025 (Jul 2025) | 0.54791 | 19.69 | 0.52309 | 0.57068 | 6 |
FQ2 2025 (Jun 2025) | 0.64322 | 187.06 | 0.62308 | 0.66986 | 4 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ3 2027 (Sep 2027) | 3.12B | -- | 3.03B | 3.21B | 5 |
FQ2 2027 (Jun 2027) | 3.04B | -- | 2.95B | 3.13B | 4 |
FQ1 2027 (Mar 2027) | 3.01B | -- | 2.93B | 3.1B | 8 |
FQ4 2026 (Oct 2026) | 3.16B | -- | 3.05B | 3.26B | 5 |
FQ3 2026 (Jul 2026) | 3.03B | -- | 2.92B | 3.12B | 5 |
FQ2 2026 (Jun 2026) | 3.08B | -- | 3B | 3.17B | 5 |
FQ1 2026 (Mar 2026) | 3.06B | 8.55 | 2.98B | 3.15B | 5 |
FQ4 2025 (Oct 2025) | 3.13B | 10.65 | 3.02B | 3.23B | 4 |
FQ3 2025 (Jul 2025) | 3B | 4.08 | 2.89B | 3.09B | 4 |
FQ2 2025 (Jun 2025) | 3.03B | 6.7 | 2.96B | 3.13B | 4 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
4
EPS # of Misses
3
EPS # of in-lines
1
Revenue # of Beats
7
Revenue # of Misses
1
Revenue # of in-lines
0
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2025 (Mar 2025) | 0.34902 | -0.54 | -0.88902 | 164.63% |
FQ4 2024 (Dec 2024) | 0.0512 | 0.0512 | 100% | |
FQ3 2024 (Sep 2024) | 0.44 | 0.44 | 100% | |
FQ2 2024 (Jun 2024) | -0.56 | -0.56 | 100% | |
FQ1 2024 (Mar 2024) | -0.73 | -0.73 | 100% | |
FQ4 2023 (Dec 2023) | 0 | 0 | NAN% | |
FQ3 2023 (Sep 2023) | 0.87 | 0.87 | 100% | |
FQ2 2023 (Jun 2023) | 4.28 | 4.28 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2025 (Mar 2025) | $2.93B | $2.79B | $-135.9M | -4.86% |
FQ4 2024 (Dec 2024) | $0B | $2.8B | $2799M | 100% |
FQ3 2024 (Sep 2024) | $0B | $2.87B | $2874M | 100% |
FQ2 2024 (Jun 2024) | $0B | $2.83B | $2830M | 100% |
FQ1 2024 (Mar 2024) | $0B | $2.74B | $2742M | 100% |
FQ4 2023 (Dec 2023) | $0B | $2.83B | $2825M | 100% |
FQ3 2023 (Sep 2023) | $0B | $2.99B | $2994M | 100% |
FQ2 2023 (Jun 2023) | $0B | $2.88B | $2879M | 100% |